Multiple Sclerosis (MS)
Evaluating MSC-NTF Therapy for Progressive Multiple Sclerosis
Mesenchymal stem cell-derived neurotrophic factor (MSC-NTF) therapy is being investigated
February 23, 2025
Mesenchymal stem cell-derived neurotrophic factor (MSC-NTF) therapy is being investigated
Stem cells in skincare are often marketed as the future
The RHA.org Your Trusted Guide to Regenerative Health
© 2025 All Rights Reserved.